cefotetan has been researched along with E coli Infections in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (54.55) | 18.7374 |
| 1990's | 5 (45.45) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nishino, T; Saito, M; Saito, T; Shibata, K; Tanino, T; Yano, K | 1 |
| Di Nola, F | 1 |
| Brook, I | 4 |
| Adams, RB; May, AK; Pruett, TL; Rosenlof, LK; Sawyer, RG | 1 |
| Hopkins, JA; Lami, JL; Wilson, SE | 1 |
| Marradi, C; Nardone, A; Nespoli, A; Padalino, P | 1 |
| Ficari, F; Tonelli, F | 1 |
| Hirai, Y; Imamura, K; Kumasaka, Y; Nakahata, H; Senda, H; Suzuki, I; Takebe, K | 1 |
1 trial(s) available for cefotetan and E coli Infections
| Article | Year |
|---|---|
Adjunctive antimicrobials in surgery of soft tissue infections: evaluation of cephalosporins and carbapenems.
Topics: Adult; Aged; Bacterial Infections; Carbapenems; Cefmetazole; Cefoperazone; Cefotetan; Cefoxitin; Cephalosporins; Drug Combinations; Drug Resistance, Microbial; Escherichia coli Infections; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Prospective Studies; Remission Induction; Skin Diseases, Infectious; Staphylococcal Infections; Streptococcal Infections; Thienamycins | 1991 |
10 other study(ies) available for cefotetan and E coli Infections
| Article | Year |
|---|---|
Therapeutic effect of cefotetan in an experimental local infection with facultative and obligate anaerobes in granuloma pouches in rats.
Topics: Animals; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; Cefazolin; Cefmetazole; Cefotetan; Cephamycins; Escherichia coli Infections; Fusobacterium Infections; Male; Microscopy, Electron, Scanning; Rats; Rats, Inbred Strains; Serratia marcescens | 1984 |
[Update on antibiotic therapy. 19) Cefotetan].
Topics: Animals; Cefotetan; Cephamycins; Drug Therapy; Escherichia coli Infections; Gram-Negative Bacteria; Humans; Kinetics; Mice; Pneumonia; Serratia marcescens | 1983 |
Comparison of cefoxitin, cefotetan, and ampicillin/sulbactam as prophylaxis for polymicrobial infection in mice.
Topics: Abscess; Ampicillin; Animals; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; Cefotetan; Cefoxitin; Cephamycins; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Male; Mice; Mice, Inbred C3H; Microbial Sensitivity Tests; Penicillins; Peritoneal Diseases; Sulbactam | 1995 |
The role of Candida albicans in the pathogenesis of experimental fungal/bacterial peritonitis and abscess formation.
Topics: Abscess; Amphotericin B; Animals; Bacteroides fragilis; Bacteroides Infections; Candida albicans; Candidiasis; Cefotetan; Cefoxitin; Clindamycin; Colony Count, Microbial; Drug Combinations; Escherichia coli; Escherichia coli Infections; Male; Mice; Mice, Inbred BALB C; Peritoneal Diseases; Peritonitis; Survival Rate | 1995 |
Prophylaxis of and therapy for polymicrobial infection in mice with cefoxitin, cefotetan, and cefmetazole.
Topics: Abdomen; Abscess; Animals; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; Cefmetazole; Cefotetan; Cefoxitin; Drug Evaluation, Preclinical; Escherichia coli Infections; Male; Mice | 1993 |
Use of cephalosporins for prophylaxis and therapy of polymicrobial infection in mice.
Topics: Abdomen; Abscess; Animals; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; Cefmetazole; Cefotetan; Cefoxitin; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Male; Mice; Microbial Sensitivity Tests; Skin Diseases, Bacterial; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus | 1993 |
Cefotetan versus clindamycin/tobramycin association in mixed aero-anaerobic peritonitis in rats.
Topics: Acute-Phase Proteins; Animals; Bacteroides Infections; Cefotetan; Clindamycin; Drug Therapy, Combination; Escherichia coli Infections; Liver; Male; Muscles; Peritonitis; Proteins; Rats; Rats, Inbred Strains; Tobramycin | 1987 |
In vitro susceptibility and in vivo efficacy of antimicrobials in the treatment of Bacteroides fragilis-Escherichia coli infection in mice.
Topics: Abscess; Ampicillin; Animals; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; Cefamandole; Cefotetan; Cefoxitin; Ceftizoxime; Cilastatin; Cilastatin, Imipenem Drug Combination; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Imipenem; Male; Mice; Skin Diseases; Sulbactam | 1989 |
Treatment of intra-abdominal abscess in a patient with complicated Crohn's disease.
Topics: Abdomen; Abscess; Adult; Cefotetan; Crohn Disease; Escherichia coli Infections; Humans; Male; Postoperative Complications; Proteus Infections | 1987 |
[In vivo antibacterial activity of cefbuperazone. Synergy of cefbuperazone for bactericidal effect with human polymorphonuclear leukocytes].
Topics: Animals; Blood Bactericidal Activity; Cefmetazole; Cefoperazone; Cefotetan; Cephamycins; Escherichia coli; Escherichia coli Infections; Male; Mice; Mice, Inbred ICR; Moxalactam; Neutrophils | 1986 |